Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.420 SEK
−83.13 M SEK
94.63 M SEK
85.57 M
About IRLAB THERAPEUTICS AB SER. A
Sector
Industry
CEO
Kristina Torfgård
Website
Headquarters
Gothenburg
Founded
2013
ISIN
SE0025400179
FIGI
BBG01VRBNJL6
IRLAB Therapeutics AB engages in the provision of novel treatments for disorders of the brain that focuses on illness in the central nervous system. The fim develops drugs for Parkinson's disease. It also offers IRL752 that targets dementia in Parkinson's disease. The company was founded in 2013 and is headquartered in Gothenburg, Sweden.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IRLAB_BTA_A is 3.330 SEK — it has increased by 0.30% in the past 24 hours. Watch IRLAB THERAPEUTICS AB BTA A stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange IRLAB THERAPEUTICS AB BTA A stocks are traded under the ticker IRLAB_BTA_A.
IRLAB_BTA_A stock has fallen by −87.67% compared to the previous week, the month change is a −87.67% fall, over the last year IRLAB THERAPEUTICS AB BTA A has showed a −87.67% decrease.
IRLAB_BTA_A reached its all-time high on Feb 27, 2020 with the price of 28.000 SEK, and its all-time low was 3.315 SEK and was reached on Jul 17, 2025. View more price dynamics on IRLAB_BTA_A chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
IRLAB_BTA_A stock is 3.92% volatile and has beta coefficient of −0.01. Track IRLAB THERAPEUTICS AB BTA A stock price on the chart and check out the list of the most volatile stocks — is IRLAB THERAPEUTICS AB BTA A there?
Today IRLAB THERAPEUTICS AB BTA A has the market capitalization of 304.08 M, it has decreased by −2.50% over the last week.
Yes, you can track IRLAB THERAPEUTICS AB BTA A financials in yearly and quarterly reports right on TradingView.
IRLAB THERAPEUTICS AB BTA A is going to release the next earnings report on Aug 27, 2025. Keep track of upcoming events with our Earnings Calendar.
IRLAB_BTA_A net income for the last quarter is −33.97 M SEK, while the quarter before that showed −5.39 M SEK of net income which accounts for −529.64% change. Track more IRLAB THERAPEUTICS AB BTA A financial stats to get the full picture.
No, IRLAB_BTA_A doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 20, 2025, the company has 33 employees. See our rating of the largest employees — is IRLAB THERAPEUTICS AB BTA A on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IRLAB THERAPEUTICS AB BTA A EBITDA is −80.13 M SEK, and current EBITDA margin is −92.83%. See more stats in IRLAB THERAPEUTICS AB BTA A financial statements.
Like other stocks, IRLAB_BTA_A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IRLAB THERAPEUTICS AB BTA A stock right from TradingView charts — choose your broker and connect to your account.